Pulmonx LUNG
NASDAQ LUNG
$1.83 +0.01 (+0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pulmonx (LUNG) Preferred Stock Liabilities (2019 - 2020)

Updated

Pulmonx's Preferred Stock Liabilities was $207.6 million in Q3 2020, up 1.1% from $205.34 million a year earlier and unchanged from the prior quarter.

Analysis

Pulmonx (LUNG) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Preferred Stock Liabilities at Pulmonx came in at $205.34 million, up 46.1% from FY2018.

  • In earlier years, Preferred Stock Liabilities was $140.54 million in FY2018.
  • Per Business Quant data, LUNG's Preferred Stock Liabilities in the three quarters before Q3 2020 was $207.6 million (Q2 2020), $207.6 million (Q1 2020) and $205.34 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn -
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn -
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn -
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn -
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn -
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn -
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn -
10 Pulmonx 74.91 Mn -244.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 207.60 Mn
Jun 30, 2020 207.60 Mn
Mar 31, 2020 207.60 Mn
Dec 31, 2019 205.34 Mn
Sep 30, 2019 205.34 Mn
API Access

Pulmonx Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=LUNG&period=max&api_key=YOUR_API_KEY